Baird Financial Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,439	Closed	-$21K	–	1530
2019 Q3	$21K	Sell	21,439 -6,350	-23%	-$6.58K	﹤0.01%	1499
2019 Q2	$31K	Hold	27,789	–	–	﹤0.01%	1516
2019 Q1	$36K	Buy	27,789 +6,168	+29%	+$7.67K	﹤0.01%	1280
2018 Q4	$20K	Sell	21,621 -3,092	-13%	-$4.74K	﹤0.01%	1261
2018 Q3	$49K	Buy	24,713 +117	+0.5%	+$246	﹤0.01%	1319
2018 Q2	$44K	Hold	24,596	–	–	﹤0.01%	1271
2018 Q1	$58K	Hold	24,596	–	–	﹤0.01%	1240
2017 Q4	$46K	Hold	24,596	–	–	﹤0.01%	1254
2017 Q3	$61K	Sell	24,596 -117	-0.5%	-$290	﹤0.01%	1222
2017 Q2	$68K	Hold	24,713	–	–	﹤0.01%	1212
2017 Q1	$75K	Buy	24,713 +4,115	+20%	+$11.7K	﹤0.01%	1204
2016 Q4	$65K	Hold	20,598	–	–	﹤0.01%	1183
2016 Q3	$70K	Hold	20,598	–	–	﹤0.01%	1182
2016 Q2	$52K	Hold	20,598	–	–	﹤0.01%	1184
2016 Q1	$52K	Sell	20,598 -1,730	-8%	-$3.86K	﹤0.01%	1203
2015 Q4	$74K	Buy	22,328 +6,840	+44%	+$20.4K	﹤0.01%	1216
2015 Q3	$38K	Buy	15,488 +2,478	+19%	+$6.42K	﹤0.01%	1234
2015 Q2	$38K	Buy	+13,010	New	+$50.4K	﹤0.01%	1297